October 20, 2023
Symposium Schedule
| Time | Event |
|---|---|
| 7:00 - 7:30 a.m. |
Breakfast A Treatment Option for the Polyneuropathy of hATTR Amyloidosis |
| 8:00 a.m. | Opening Remarks |
| Session 1 |
ATTR Amyloidosis |
| Chairs | James Fang, MD; Mathew Maurer, MD |
| 8:10 a.m. | Clinical Presentation of TTR Spencer Carter, MD University of Utah, Salt Lake City, Utah |
| 8:35 a.m. | Stabilizers and Silencers Jose N. Nativi-Nicolau, MD Mayo Clinic, Jacksonville, Florida |
| 9:00 a.m. | Neurological Presentations in Amyloidosis Kelsey Barrell, MD University of Utah, Salt Lake City, Utah |
| 9:25 a.m. |
The Quest for Improving Quality of Life For Those With Amyloidosis |
| 9:50 a.m. |
Break |
| Session 2 |
AL Amyloidosis |
| Chairs | Josephine Abraham, MD, MPH; Ramiro Garzon, MD |
| 10:20 a.m. |
Clinical Presentation and Review of Current and Novel Diagnostic Strategies |
| 10:45 a.m. |
Treatment Paradigms for AL Amyloidosis: Newly Diagnosed |
| 11:10 a.m. |
Treatment Paradigms for AL Amyloidosis: Relapsed/Refractory |
| 11:35 a.m. |
Improving Organ Function and Recovery: Depth of Response and Anti-Fibril Strategies |
| 12:00 p.m. |
Lunch |
| Session 3 |
Keynote Address |
| Chairs | Spencer Carter, MD; Jose N. Nativi-Nicolau, MD |
| 1:00 p.m. |
Cardiology Grand Rounds Keynote Address: The Future of Amyloidosis Therapy |
| 1:50 p.m. | Role of Imaging in Amyloidosis Ahmad Masri, MD, MS Oregon Health and Science University, Portland, Oregon |
| 2:15 p.m. |
AI Approaches to Identifying Patients At Risk of Amyloidosis |
| 2:40 p.m. |
Optimizing Clinical and Research Flow in an Amyloidosis Referral Program |
| 3:05 p.m. | Break |
| Session 4 |
The Great Debates |
| Chairs | Amandeep Godara, MBBS; Josef Stehlik, MD, MPH |
| 3:30 p.m. |
PRO: We should screen patients with ortho manifestations for TTR amyloidosis |
| 3:45 p.m. | CON: We should screen patients with ortho manifestations for TTR amyloidosis Ahmad Masri, MD, MS Oregon Health and Science University, Portland, Oregon |
| 4:00 p.m. | Discussion |
| 4:15 p.m. | PRO: Role of upfront stem cell transplant in AL amyloidosis Anita D'Souza, MD Medical College of Wisconsin, Milwaukee, Wisconsin |
| 4:30 p.m. | CON: Role of upfront stem cell transplant in AL amyloidosis Tibor Kovacsovics, MD City of Hope Phoenix, Phoenix, Arizona |
| 4:45 p.m. | Discussion |
| 5:00 p.m. | Closing Remarks |
| 5:30 p.m. |
Symposium Dinner Presentation - Salt Lake City Marriott University Park The Journey Through Diagnosis and Treatment: From a Patient's Perspective |